Cipace: Improper Authorization
CVE-2024-50617 is a high-severity improper authorization vulnerability in Cipace from Cipplanner, with a CVSS 3.1 base score of 7.5 out of 10. It can be exploited remotely over the network by an unauthenticated attacker, without any action from a user. The record lists version 9.17 as the first without the flaw, so updating Cipace to that release or later removes the exposure. There is no confirmed exploitation so far. EPSS estimates a 0.28% chance of exploitation within 30 days, which is low compared with other CVEs.
High severity with no evidence of exploitation so far.
What to do
- Update Cipace to 9.17 or a later version.
- Read the advisory on cipplanner.com for workarounds and exact fixed builds.
- Until you can update, restrict network access to the affected service so it is not reachable from untrusted networks.
Affected products and versions
| Vendor | Product | Affected versions | Fixed in |
|---|---|---|---|
| Cipplanner | Cipace | before 9.17 | 9.17 |
Version data comes from NVD's product matching. Confirm against the vendor advisory before deciding you are unaffected.
How the severity score breaks down
- Attack vector
- NetworkCan be exploited remotely over a network, including the internet.
- Attack complexity
- LowNo special conditions are needed; the attack works reliably.
- Privileges required
- NoneNo account or login is needed.
- User interaction
- NoneNo action by a victim is required.
- Scope
- UnchangedImpact stays within the vulnerable component.
- Confidentiality
- HighAll data handled by the component can be read.
- Integrity
- NoneNothing can be modified.
- Availability
- NoneAvailability is not affected.
Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N. Scored by CISA (ADP).
Official description
Vulnerabilities in the File Download and Get File handler components in CIPPlanner CIPAce before 9.17 allow attackers to download unauthorized files. An authenticated user can easily change the file id parameter or pass the physical file path in the URL query string to retrieve the files. (Retrieval is not intended without correct data access configured for documents.)
Source: the CVE record as published by its numbering authority, via NVD and CVE.org.
The underlying weakness: Improper Authorization
The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action.
How developers prevent this class of flaw
- Divide the product into anonymous, normal, privileged, and administrative areas. Reduce the attack surface by carefully mapping roles with data and functionality. Use role-based access control (RBAC) to enforce the roles at the appropriate boundaries. Note that this approach may not protect against horizontal authorization, i.e., it will not protect a user from attacking others with the same role.
- Ensure that you perform access control checks related to your business logic. These checks may be different than the access control checks that you apply to more generic resources such as files, connections, processes, memory, and database records. For example, a database may restrict access for medical records to a specific database user, but each record might only be intended to be accessible to the patient and the patient's doctor.
- Use a vetted library or framework that does not allow this weakness to occur or provides constructs that make this weakness easier to avoid. For example, consider using authorization frameworks such as the JAAS Authorization Framework and the OWASP ESAPI Access Control feature.
Timeline
- CVE record published.
- CISA published its SSVC assessment (exploitation: none, automatable: yes, technical impact: partial).
- Record last changed materially (score, affected products, status or references).
References
Other vulnerabilities in Cipace
- 8.8 High severity
- 8.8 High severity
Recent Improper Authorization vulnerabilities
- 9.8 Critical severity
- 7.5 High severity
- 9.8 Critical severity
- 7.1 High severity
- 8.2 High severity
- 9.9 Critical severity
Spotted an error? Tell us.